Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer

Autor: Bellmunt, J. *, Eigl, B.J., Senkus, E., Loriot, Y., Twardowski, P., Castellano, D., Blais, N., Sridhar, S.S., Sternberg, C.N., Retz, M., Pal, S., Blumenstein, B., Jacobs, C., Stewart, P.S., Petrylak, D.P.
Zdroj: In Annals of Oncology October 2017 28(10):2481-2488
Databáze: ScienceDirect